中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
17期
14-16
,共3页
许丽华%车小群%宋丽君%邹琳%陈碧%庞小艳
許麗華%車小群%宋麗君%鄒琳%陳碧%龐小豔
허려화%차소군%송려군%추림%진벽%방소염
体外受精-胚胎移植(IVF-ET)%雪诺同8%%黄体支持
體外受精-胚胎移植(IVF-ET)%雪諾同8%%黃體支持
체외수정-배태이식(IVF-ET)%설낙동8%%황체지지
In-vitro fertilization-embryo transfer%Progesterone sustained-released vaginal gel%Luteal phase support
目的:探讨阴道放置黄体酮阴道缓释凝胶(商品名:雪诺同8%)在体外受精(IVF)和卵细胞浆内单精子注射(ICSI)术后黄体支持的临床疗效。方法回顾性分析了进行体外受精-胚胎移植(IVF-ET)138个新鲜周期的患者临床资料,按不同黄体支持方法分两组:黄体酮肌内注射组(A组)60例,阴道放置雪诺同8%(B组)78例。观察两组的着床率、临床妊娠率、早期流产率以及药物不良反应发生率。结果138个新鲜周期中,术后随访期间妊娠共81例,总临床妊娠率为58.7%(81/138), B组的临床妊娠率高于A组的临床妊娠率,差异有统计学意义(P<0.05), B组的不良反应率明显低于A组的不良反应率,差异有统计学意义(P<0.05)。B组的着床率、早期流产率与A组比较,差异均无统计学意义(P>0.05)。结论阴道放置雪诺酮8%在IVF-ET术后进行黄体支持是有效的黄体支持方案,可提高临床妊娠率,且使用简便,可避免患者由于注射黄体酮产生的不良反应。
目的:探討陰道放置黃體酮陰道緩釋凝膠(商品名:雪諾同8%)在體外受精(IVF)和卵細胞漿內單精子註射(ICSI)術後黃體支持的臨床療效。方法迴顧性分析瞭進行體外受精-胚胎移植(IVF-ET)138箇新鮮週期的患者臨床資料,按不同黃體支持方法分兩組:黃體酮肌內註射組(A組)60例,陰道放置雪諾同8%(B組)78例。觀察兩組的著床率、臨床妊娠率、早期流產率以及藥物不良反應髮生率。結果138箇新鮮週期中,術後隨訪期間妊娠共81例,總臨床妊娠率為58.7%(81/138), B組的臨床妊娠率高于A組的臨床妊娠率,差異有統計學意義(P<0.05), B組的不良反應率明顯低于A組的不良反應率,差異有統計學意義(P<0.05)。B組的著床率、早期流產率與A組比較,差異均無統計學意義(P>0.05)。結論陰道放置雪諾酮8%在IVF-ET術後進行黃體支持是有效的黃體支持方案,可提高臨床妊娠率,且使用簡便,可避免患者由于註射黃體酮產生的不良反應。
목적:탐토음도방치황체동음도완석응효(상품명:설낙동8%)재체외수정(IVF)화란세포장내단정자주사(ICSI)술후황체지지적림상료효。방법회고성분석료진행체외수정-배태이식(IVF-ET)138개신선주기적환자림상자료,안불동황체지지방법분량조:황체동기내주사조(A조)60례,음도방치설낙동8%(B조)78례。관찰량조적착상솔、림상임신솔、조기유산솔이급약물불량반응발생솔。결과138개신선주기중,술후수방기간임신공81례,총림상임신솔위58.7%(81/138), B조적림상임신솔고우A조적림상임신솔,차이유통계학의의(P<0.05), B조적불량반응솔명현저우A조적불량반응솔,차이유통계학의의(P<0.05)。B조적착상솔、조기유산솔여A조비교,차이균무통계학의의(P>0.05)。결론음도방치설낙동8%재IVF-ET술후진행황체지지시유효적황체지지방안,가제고림상임신솔,차사용간편,가피면환자유우주사황체동산생적불량반응。
Objective To investigate the therapeutic effect of progesterone sustained-released vaginal gel( Crinone8%) as luteal phase support in in-vitro fertilization(IVF) and intracytoplamsic sperm injection( ICSI) cycles. Methods Clinical data of 138 cycles were analyzed retrospectively. They were divided into two groups according different luteal support randomly. Group A:60 cases, with progesterone as luteal support. Group B:78 cases, with Crinone 8% Gel as luteal support.Implantation rate, clinical pregnancy rate, miscarriage rate and adverse drug reaction rate were observed. Results All of the 138 cases, 81 became pregnant within the follow up. The total clinical pregnancy rates were 58.7%(81/138). The pregnancy rates of group B were significantly higher than group A. The adverse drug reaction rate of group B was lower than group A, its’differences had statistic significance(P<0.05). There were no statistical differences between the 2 groups in implantation rate and miscarriage rate(P>0.05). Conclusion It is an effective program with vaginal administration of Crinone 8%gel as luteal support in in-vitro fertilization-embryo transfert. It can improve clinical pregnancy rate. Furthermore, it can avoid adverse drug reaction from the injection of progesterone and use conveniently.